Deep learning-based image analysis identifies a DAT-negative subpopulation of dopaminergic neurons in the lateral Substantia nigra.

Journal: Communications biology
PMID:

Abstract

Here we present a deep learning-based image analysis platform (DLAP), tailored to autonomously quantify cell numbers, and fluorescence signals within cellular compartments, derived from RNAscope or immunohistochemistry. We utilised DLAP to analyse subtypes of tyrosine hydroxylase (TH)-positive dopaminergic midbrain neurons in mouse and human brain-sections. These neurons modulate complex behaviour, and are differentially affected in Parkinson's and other diseases. DLAP allows the analysis of large cell numbers, and facilitates the identification of small cellular subpopulations. Using DLAP, we identified a small subpopulation of TH-positive neurons (~5%), mainly located in the very lateral Substantia nigra (SN), that was immunofluorescence-negative for the plasmalemmal dopamine transporter (DAT), with ~40% smaller cell bodies. These neurons were negative for aldehyde dehydrogenase 1A1, with a lower co-expression rate for dopamine-D2-autoreceptors, but a ~7-fold higher likelihood of calbindin-d28k co-expression (~70%). These results have important implications, as DAT is crucial for dopamine signalling, and is commonly used as a marker for dopaminergic SN neurons.

Authors

  • Nicole Burkert
    Institute of Applied Physiology, Medical Faculty, Ulm University, 89081, Ulm, Germany.
  • Shoumik Roy
    Institute of Applied Physiology, Medical Faculty, Ulm University, 89081, Ulm, Germany. shoumik.roy@uni-ulm.de.
  • Max Häusler
    Institute of Applied Physiology, Medical Faculty, Ulm University, 89081, Ulm, Germany.
  • Dominik Wuttke
    Wolution GmbH & Co. KG, 82152, Munich, Germany.
  • Sonja Müller
    Institute of Applied Physiology, Medical Faculty, Ulm University, 89081, Ulm, Germany.
  • Johanna Wiemer
    Institute of Applied Physiology, Medical Faculty, Ulm University, 89081, Ulm, Germany.
  • Helene Hollmann
    Institute of Applied Physiology, Medical Faculty, Ulm University, 89081, Ulm, Germany.
  • Marvin Oldrati
    Institute of Applied Physiology, Medical Faculty, Ulm University, 89081, Ulm, Germany.
  • Jorge Ramirez-Franco
    UMR_S 1072, Aix Marseille Université, INSERM, Faculté de Médecine Secteur Nord, Marseille, France.
  • Julia Benkert
    Institute of Applied Physiology, Medical Faculty, Ulm University, 89081, Ulm, Germany.
  • Michael Fauler
    Institute of General Physiology, Medical Faculty, Ulm University, 89081, Ulm, Germany.
  • Johanna Duda
    Institute of Applied Physiology, Medical Faculty, Ulm University, 89081, Ulm, Germany.
  • Jean-Marc Goaillard
    UMR_S 1072, Aix Marseille Université, INSERM, Faculté de Médecine Secteur Nord, Marseille, France.
  • Christina Pötschke
    Institute of Applied Physiology, Medical Faculty, Ulm University, 89081, Ulm, Germany.
  • Moritz Münchmeyer
    Wolution GmbH & Co. KG, 82152, Munich, Germany.
  • Rosanna Parlato
    Institute of Applied Physiology, Medical Faculty, Ulm University, 89081, Ulm, Germany.
  • Birgit Liss
    Institute of Applied Physiology, Medical Faculty, Ulm University, 89081, Ulm, Germany. birgit.liss@uni-ulm.de.